Get answers to common inquiries on Parse features, compliance, data insights, and mass tort applications. Still have questions? Reach out to us.
Who is Milliman Parse built for?
Parse is used by organizations that manage high‑volume legal intake and need earlier, more defensible decisions, including:
Parse is designed for teams that want discipline at intake—not more noise downstream.
What is Milliman Parse—and what is it not?
Milliman Parse is claims‑first legal intake intelligence.
It surfaces verified prescription and medical claims insight and validates consent at intake so you can decide whether an injury case should move forward before initiating medical record retrieval.
Parse is not a medical record‑retrieval service, chart abstraction tool, or document‑pulling platform. Many customers still use records vendors downstream; Parse helps them use those vendors more strategically by focusing effort only where the case warrants it.
How is Parse different from records‑first intake or “faster records” platforms?
Speed matters. But timing matters more.
Records‑first platforms accelerate access to medical records after you’ve already committed time, money, and operational capacity to a case. Parse reverses that sequence.
By bringing claims insight forward to intake, Parse helps teams determine whether real‑world care patterns support the alleged injury at all—before records are ordered. In practice, this reduces unnecessary retrieval while improving outcomes for the cases that proceed.
What data does Parse use at intake? And why claims data first?
Parse uses verified medical and prescription claims data, not full medical records.
Claims data is structured, consistent, and available much earlier than designated record sets. That makes it uniquely suited for early triage, prioritization, and go/no‑go intake decisions, when leverage is highest and costs are lowest.
How quickly does Parse return insight at intake?
Claims insight is typically returned in seconds, allowing teams to apply Parse to live intake, pilot within an active mass tort, or benchmark performance quickly.
Because Parse operates at the front door, value is realized almost immediately and compounds throughout the lifecycle.
Does Parse replace our case management system or vendors?
No. Milliman Parse is designed to complement—not replace—your existing ecosystem.
Parse integrates with intake workflows and case management systems, informs when downstream vendors should be engaged, and reduces rework and wasted spend across the lifecycle. Many organizations view Parse as the intelligence layer that makes every downstream system perform better.
How does Milliman Parse handle HIPAA and legal‑grade compliance?
Compliance is foundational to Parse—not an afterthought.
Parse is built with purpose‑specific HIPAA pathways for legal use, minimum‑necessary data access aligned to intake decisions, standardized authorization templates, and immutable audit logs. This approach reflects Milliman’s long history operating in highly regulated healthcare environments and ensures defensibility at scale.
How does Milliman Parse support high‑volume mass‑tort intake?
Mass‑tort intake is a game of volume, speed, and discipline. Parse helps you manage scale by surfacing verified claims insight at intake, allowing you to quickly assess whether claimants show care patterns consistent with the alleged injury—before investing time or money downstream.
This early insight helps intake teams prioritize stronger cohorts, throttle intake intelligently, and avoid flooding operations with cases that languish later.
Can Milliman Parse screen large lead lists or early‑stage dockets?
Yes. Parse is well‑suited for batch and cohort‑based analysis in mass‑tort scenarios.
Use Parse to screen high volumes of inbound leads, identify cohorts showing meaningful care activity, and flag missing or inconsistent patterns early. This enables smarter docket building and more efficient use of legal and operational resources.
How does Milliman Parse help reduce dead files in mass torts?
Dead files often emerge when claimants lack sufficient care history, show early inconsistencies, or fail to support the alleged timeline.
By exposing claims patterns at intake, Parse helps teams filter out weak cases earlier, prevent unnecessary file creation, and focus capacity on matters most likely to progress. The results are cleaner dockets and lower cost per matter.
How does Milliman Parse help decide which medical records to pursue—and when?
While Parse is not a record‑retrieval service, it plays a critical role in directing record retrieval more intelligently.
By surfacing verified claims insight at intake, Parse helps teams identify relevant providers, timeframes, and types of care—so record requests are targeted, defensible, and aligned to the alleged injury. Many organizations use Parse to reduce overall retrieval volume while improving outcomes on the cases that move forward.
How does Milliman Parse maintain defensibility and compliance at mass‑tort scale?
At mass‑tort scale, compliance risk multiplies due to volume, vendor sprawl, and inconsistent authorizations.
Parse embeds standardized authorization flows, minimum‑necessary data access, purpose‑specific HIPAA pathways, and immutable audit logs straight into intake, creating consistency and defensibility even under regulatory or court scrutiny.
Can Milliman Parse adapt as mass‑tort criteria and medical understanding evolve?
Yes. Mass‑tort programs are dynamic, and Parse is designed to adapt.
Teams can adjust screening criteria, re‑evaluate cohorts as insight evolves, and expand Parse from early intake to broader programs without rebuilding workflows mid‑stream.
Who typically owns Milliman Parse in a mass‑tort organization?
Ownership varies, but Parse is commonly used by mass‑tort intake leaders, legal operations teams, retainer organizations, and litigation service companies.
In practice, Parse acts as a shared intelligence layer that aligns intake, operations, and downstream vendors for better decisions.
What performance metrics improve first with Milliman Parse?
Teams often see early, measurable improvements in conversion quality, time‑to‑case readiness, cost per matter, reduction of dead files, and consistency of consent and intake documentation.
Because Parse operates at intake, these gains compound across the case lifecycle.
How quickly can we pilot Milliman Parse on a mass‑tort matter?
You can typically pilot Parse quickly by applying it to a subset of inbound leads or an early‑stage docket.
Because insight is returned in minutes, organizations can benchmark impact within weeks and make informed decisions about scaling Parse across the broader program.